Medium-term follow-up data after sentinel node biopsy alone for breast cancer

European Journal of Surgical Oncology

Volumn 32, Issue 10, 2006, Pages 1180-1185

  Haid, A ^a   Knauer, M ^a   Koberle Wuhrer R ^a   Ammann, K ^a   Koller, L ^a   Eiter, H ^a   Lang, A ^a   Wenzl, E ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Breast cancer; Follow up; Regional lymph node recurrence; Sentinel node biopsy

Indexed keywords

ANTINEOPLASTIC AGENT; DYE; ESTROGEN; HORMONE; PROGESTERONE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CLINICAL STUDY; COLLOID; CONTROLLED STUDY; DEATH; DIAGNOSTIC ACCURACY; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; LONGITUDINAL STUDY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL AUDIT; METASTASIS; MORBIDITY; OBSERVATIONAL STUDY; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SENTINEL LYMPH NODE BIOPSY;

EID: 33751260657     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.04.010     Document Type: Article

References (57)

1. Giuliano A.E., Kirgan D.M., Guenther J.M., et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220 (1994) 391-398 discussion 398-401
2. Tafra L., Lannin D.R., Swanson M.S., et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 233 (2001) 51-59
3. Goyal A., Newcombe R.G., Mansel R.E., et al. Sentinel lymph node biopsy in patients with multifocal breast cancer. Eur J Surg Oncol 30 (2004) 475-479
4. Veronesi U., Paganelli G., Viale G., et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 91 (1999) 368-373
5. Gould E.A., Winship T., Philbin P.H., et al. Observations on a "sentinel node" in cancer of the parotid. Cancer 13 (1960) 77-78
6. Cabanas R.M. An approach for the treatment of penile carcinoma. Cancer 39 (1977) 456-466
7. Borgstein P.J., Meijer S., Pijpers R.J., et al. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg 232 (2000) 81-89
8. Giuliano A.E., Dale P.S., Turner R.R., Morton D.L., Evans S.W., and Krasne D.L. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222 (1995) 394-399 discussion 399-401
9. Wilke L.G., and Giuliano A. Sentinel lymph node biopsy in patients with early-stage breast cancer: status of the National Clinical Trials. Surg Clin North Am 83 (2003) 901-910
10. Giuliano A.E., Haigh P.I., Brennan M.B., et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18 (2000) 2553-2559
11. Haid A., Koberle-Wuhrer R., Knauer M., et al. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 73 (2002) 31-36
12. Veronesi U., Paganelli G., Viale G., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349 (2003) 546-553
13. Purushotham A.D., Upponi S., Klevesath M.B., et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23 (2005) 4312-4321
14. Cox C.E., Pendas S., Cox J.M., et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227 (1998) 645-651 discussion 651-643
15. Schwartz G.F., Giuliano A.E., and Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 94 (2002) 2542-2551
16. Lyman G.H., Giuliano A.E., Somerfield M.R., et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23 (2005) 7703-7720
17. Krag D., and Ashikaga T. The design of trials comparing sentinel-node surgery and axillary resection. N Engl J Med 349 (2003) 603-605
18. Orr R.K. The impact of prophylactic axillary node dissection on breast cancer survival - a Bayesian meta-analysis. Ann Surg Oncol 6 (1999) 109-116
19. Haid A.K.-W.R., Offner F., Jasarevic Z., et al. Klinische Wertigkeit und zukünftige Aspekte der "Sentinel Node Biopsy" beim Mammakarzinom. Der Chirurg 74 (2003) 657-664
20. Singletary S.E., Allred C., Ashley P., et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20 (2002) 3628-3636
21. Goldhirsch A., Glick J.H., Gelber R.D., et al. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. J Natl Cancer Inst 90 (1998) 1601-1608
22. Konstantiniuk P.K.E., Haid A., Bauer C., et al. Das MCDBP (multi center database project). Acta Chir Austriaca 33 (2001) 200-201
23. Haid A., Kuehn T., Konstantiniuk P., et al. Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol 28 (2002) 705-710
24. Goldhirsch A., Wood W.C., Gelber R.D., Coates A.S., Thurlimann B., and Senn H.J. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21 (2003) 3357-3365
25. Mansel R.E.G.A., Newcombe R.G., and on behalf of the ALMANAC Trialist Group. Objective assessment of lymphedema, shoulder function and sensory deficit after sentinel node biopsy for invasive breast cancer: ALMANAC Trial. In: Lippman M.E. (Ed). San Antonio Breast Cancer Symposium (2004), Kluwer Academic Publishers, San Antonio S12
26. Fisher B., Redmond C., Fisher E.R., et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312 (1985) 674-681
27. Veronesi U., Salvadori B., Luini A., et al. Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg 211 (1990) 250-259
28. Recht A., Pierce S.M., Abner A., et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 9 (1991) 988-996
29. Senofsky G.M., Moffat Jr. F.L., Davis K., et al. Total axillary lymphadenectomy in the management of breast cancer. Arch Surg 126 (1991) 1336-1341 discussion 1341-1332
30. Fredriksson I., Liljegren G., Arnesson L.G., et al. Consequences of axillary recurrence after conservative breast surgery. Br J Surg 89 (2002) 902-908
31. Chua B., Ung O., and Boyages J. Competing considerations in regional nodal treatment for early breast cancer. Breast J 8 (2002) 15-22
32. Harder LHF. Outcome and complications after standard axillary lymph node dissection in breast cancer. Thesis, University of Basel, Switzerland; 2002.
33. Langer I., Marti W.R., Guller U., et al. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 241 (2005) 152-158
34. Schrenk P., Hatzl-Griesenhofer M., Shamiyeh A., et al. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol 77 (2001) 165-170
35. Roumen R.M., Kuijt G.P., Liem I.H., et al. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 88 (2001) 1639-1643
36. Roka S.K.P., Heck D., Schrenk P., et al. Axillary recurrence after sentinel node biopsy. Eur Surg 34 (2002) 280-282
37. Chung M.A., Steinhoff M.M., and Cady B. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 184 (2002) 310-314
38. Blanchard D.K., Donohue J.H., Reynolds C., et al. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138 (2003) 482-487 discussion 487-488
39. Badgwell B.D., Povoski S.P., Abdessalam S.F., et al. Patterns of recurrence after sentinel lymph node biopsy for breast cancer. Ann Surg Oncol 10 (2003) 376-380
40. Reitsamer R., Peintinger F., Prokop E., Menzel C., Cimpoca W., and Rettenbacher L. Sentinel lymph node biopsy alone without axillary lymph node dissection - follow up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 29 (2003) 221-223
41. van der Vegt B., Doting M.H., Jager P.L., Wesseling J., and de Vries J. Axillary recurrence after sentinel lymph node biopsy. Eur J Surg Oncol 30 (2004) 715-720
42. Taback B.H.N., Conway K., Giuliano A.E. Recurrence patterns following a negative sentinel node biopsy in patients with early-stage breast cancer. ASCO Proceedings 2004; 560.
43. Naik A.M., Fey J., Gemignani M., et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 240 (2004) 462-468 discussion 468-471
44. Torrenga H., Fabry H., van der Sijp J.R., van Diest P.J., Pijpers R., and Meijer S. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis. J Surg Oncol 88 (2004) 4-7 discussion 7-8
45. Reitsamer R., Peintinger F., Prokop E., Rettenbacher L., and Menzel C. 200 Sentinel lymph node biopsies without axillary lymph node dissection - no axillary recurrences after a 3-year follow-up. Br J Cancer 90 (2004) 1551-1554
46. Kokke M.C., Jannink I., Barneveld P.C., et al. Incidence of axillary recurrence in 113 sentinel node negative breast cancer patients: a 3-year follow-up study. Eur J Surg Oncol 31 (2005) 221-225
47. Snoj M., Bracko M., and Zagar I. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node. Croat Med J 46 (2005) 377-381
48. Jeruss J.S., Winchester D.J., Sener S.F., et al. Axillary recurrence after sentinel node biopsy. Ann Surg Oncol 12 (2005) 34-40
49. Zavagno G., Carcoforo P., Franchini Z., et al. Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients. Eur J Surg Oncol 31 7 (2005) 715-720
50. Veronesi U., Galimberti V., Mariani L., et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer 41 (2005) 231-237
51. Fant J.S., Grant M.D., Knox S.M., et al. Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 10 (2003) 126-130
52. Kuehn T., Klauss W., Darsow M., et al. Long-term morbidity following axillary dissection in breast cancer patients - clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 64 (2000) 275-286
53. Erickson V.S., Pearson M.L., Ganz P.A., Adams J., and Kahn K.L. Arm edema in breast cancer patients. J Natl Cancer Inst 93 (2001) 96-111
54. McGuckin M.A., Cummings M.C., Walsh M.D., Hohn B.G., Bennett I.C., and Wright R.G. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 73 (1996) 88-95
55. Cote R.J., Peterson H.F., Chaiwun B., et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 354 (1999) 896-900
56. Veronesi U., Paganelli G., Galimberti V., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349 (1997) 1864-1867
57. Reynolds C., Mick R., Donohue J.H., et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?. J Clin Oncol 17 (1999) 1720-1726